Home » Posts tagged with » Schizophrenia (Page 2)

Schizophrenia: Could lack of nutrients in pregnancy be a cause?

Using mice, scientists identify a mechanism that links lack of omega-3 and omega-6 fatty acids in pregnancy to schizophrenia-like symptoms in offspring.

Schizophrenia: Could lack of nutrients in pregnancy be a cause?

Using mice, scientists identify a mechanism that links lack of omega-3 and omega-6 fatty acids in pregnancy to schizophrenia-like symptoms in offspring.

Schizophrenia ‘voices’ quietened by magnetic stimulation

Schizophrenia is notoriously difficult to treat, but a recent study shows that stimulating the brain with magnetic pulses reduces auditory hallucinations.

Schizophrenia ‘voices’ quietened by magnetic stimulation

Schizophrenia is notoriously difficult to treat, but a recent study shows that stimulating the brain with magnetic pulses reduces auditory hallucinations.

Brain stimulation may improve cognitive performance in people with schizophrenia

Brain stimulation could be used to treat cognitive deficits frequently associated with schizophrenia, according to a new study from King’s College London.

Schizophrenia breakthrough: Halting protein degradation is key

A reduction in DISC1 plays a role in schizophrenia, and a new study investigates how this protein is degraded while attempting to apply its brakes.

Cannabis-derived compound may help treat schizophrenia

New research investigates the potential of the cannabis compound cannabidiol for treating cognitive symptoms in patients with schizophrenia.

Discovery of new pathway in brain has implications for schizophrenia treatment

Neuroscientists at Tufts University School of Medicine have discovered a new signaling pathway that directly connects two major receptors in the brain associated with learning and memory – the…

Antipsychotics: Do they do more harm than good?

A new study investigates the benefits and side effects of antipsychotic medication for people with schizophrenia and related mental health conditions.

FDA approves first drug to treat tardive dyskinesia

The U.S. Food and Drug Administration has approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia. This is the first drug approved by the FDA for this condition.